SCHEMBL5675089

SCHEMBL5675089

CC(O)C(Br)OCCOCCCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5574550 0.79 MEN1 (0.31)
SCHEMBL14320681 0.79 ALDH1A1 (0.33)
SCHEMBL2477058 0.79 ALDH1A1 (0.33)
SCHEMBL2474237 0.79 ALDH1A1 (0.33)
SCHEMBL1003610 0.79 ALDH1A1 (0.33)
SCHEMBL20357790 0.73 LMNA (0.35)
SCHEMBL2993042 0.73
SCHEMBL20357691 0.73 MEN1 (0.31)
SCHEMBL10819605 0.73
SCHEMBL20774152 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1653996-A2 USE OF GALACTOSE OXIDASE FOR SELECTIVE CHEMICAL CONJUGATION OF PROTRACTOR MOLECULES TO PROTEINS OF THERAPEUTIC INTEREST Novo Nordisk Health Care AG (CH) 2006-05-10 EP disclosed
WO-2005014035-A2 USE OF GALACTOSE OXIDASE FOR SELECTIVE CHEMICAL CONJUGATION OF PROTRACTOR MOLECULES TO PROTEINS OF THERAPEUTIC INTEREST NOVO NORDISK HEALTH CARE AG (CH) 2005-02-17 WO disclosed